PhRMA trying to water down White House drug pricing orders

The White House is finalizing executive orders on drug pricing and is expected to release them this week.

PhRMA and its members are mobilizing to head-off or dilute plans for administrative steps that would seek to link U.S. drug prices to international

Read the full 424 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers